Peter Wijngaard's most recent trade in Hepion Pharmaceuticals Inc was a trade of 20,000 Common Stock done at an average price of $1.9 . Disclosure was reported to the exchange on Dec. 18, 2020.
Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
---|---|---|---|---|---|---|---|---|---|---|
Hepion Pharmaceuticals Inc | Peter Wijngaard | Director | Purchase of securities on an exchange or from another person at price $ 1.91 per share. | 18 Dec 2020 | 20,000 | 20,000 (0%) | 0% | 1.9 | 38,200 | Common Stock |
Hepion Pharmaceuticals Inc | Peter Wijngaard | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 19 Aug 2020 | 30,000 | 60,000 | - | - | Stock Options | |
Hepion Pharmaceuticals Inc | Peter Wijngaard | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 25 Jun 2020 | 30,000 | 30,000 | - | - | Stock Options |